CloSys

About:

CloSys develops hemostatic devices used for rapid vascular closure for anti-coagulated patients.

Description:

CloSys Corporation develops hemostatic devices. It offers hemostatic devices, which are used for rapid vascular closure in anticoagulated patients.

Total Funding Amount:

$2.38M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Minneapolis, Minnesota, United States

Founded Date:

2005-01-01

Contact Email:

gervaise(AT)comcast.net

Founders:

Karol Nowakowski

Number of Employees:

1-10

Last Funding Date:

2016-11-14

IPO Status:

Private

Industries: